SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-002068
Filing Date
2024-01-11
Accepted
2024-01-11 16:15:22
Documents
12
Period of Report
2024-01-09
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36463
  Complete submission text file 0001493152-24-002068.txt   207801

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE vbiv-20240109.xsd EX-101.SCH 3024
3 XBRL LABEL FILE vbiv-20240109_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE vbiv-20240109_pre.xml EX-101.PRE 22365
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3221
Mailing Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 24529426
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)